Transcription factor AP-2 and monoaminergic functions in the central nervous system

Journal of Neural Transmission

Volumn 112, Issue 10, 2005, Pages 1281-1296

  Damberg, M ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Box 593 ^*  (Sweden)

Author keywords

Antidepressants; Monoamines; Personality; Psychiatric disorders; Serotonin; Transcription factors

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; CITALOPRAM; IMIPRAMINE; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR AP 2; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BINDING SITE; BRAIN DEVELOPMENT; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; DNA POLYMORPHISM; EATING DISORDER; ENZYME ACTIVITY; FOREBRAIN; GENE CONTROL; GENE EXPRESSION; GENOTYPE; HEREDITY; HUMAN; METABOLITE; MONOAMINERGIC SYSTEM; NERVE CELL DIFFERENTIATION; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; PERSONALITY; PHENOTYPE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SCHIZOPHRENIA;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; HUMANS; MENTAL DISORDERS; PERSONALITY; TRANSCRIPTION FACTOR AP-2;

EID: 25444528682     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0325-1     Document Type: Article

References (96)

1. J Angst R Sellaro KR Merikangas J Endicott 2001 The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 104 110 116
2. SE Antonarkis JL Blouin AE Pulver P Wolyniec VK Lasseter G Nestadt L Kasch R Babb HH Kazazian B Dombroski M Kimberland J Ott D Housman M Karayiorgou CJ Maclean 1995 Schizophrenia susceptibility and chromosome 6p24-22. Nat Genet 11 235 236
3. F Baskin YP Li LB Hersh RM Davis RN Rosenberg 1997 An AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience 76 821 827
4. BJ Bassam G Caetano-Anolles PM Gresshoff 1991 Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196 80 83
5. C Berggård M Damberg L Oreland 2003 Chronic citalopram treatment induces time-dependent changes in the expression and DNA-binding activity of transcription factor AP-2 in rat brain. Eur Neuropsychopharmacol 13 1 11 17
6. Berggård C, Damberg M, Oreland L (2005) Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram. BMC Pharmacol 21;5(1): 1
7. P Blier Y Chaput C de Montigny 1988 Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 337 246 254
8. P Blier C de Montigny 1994 Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15 7 220 226
9. JM Bosher NF Totty JJ Hsuan T Williams HC Hurst 1996 A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13 1701 1707
10. CC Bradely RD Blakely 1997 Alternative splicing of the human serotonin transporter gene. J Neurochem 69 1356 1367
11. DT Brewerton 1995 Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 20 561 590
12. TD Brewerton DC Jimerson 1996 Studies of serotonin function in anorexia nervosa. Psychiatry Res 62 1 31 42
13. T Butt SK Karathanasis 1995 Transcription factors as drug targets: opportunities for therapeutic selectivity. Gene Expr 4 319 336
14. C Chazaud M Oulad-Abdelghani P Bouillet D Decimo P Chambon P Dolle 1996 AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 54 83 94
15. Cohen J (1988) Statistical power analysis for the behavioural sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
16. DE Comings 1998 Polymorphic inheritance and micro/minisatellites. Mol Psychiatry 3 21 31
17. A Cravchik D Goldman 2000 Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch Gen Psychiatry 57 1105 1114
18. M Damberg H Garpenstrand J Alfredsson J Ekblom K Forslund G Rylander L Oreland 2000a A polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits. Mol Psychiatry 5 220 224
19. M Damberg H Garpenstrand C Berggard M Åsberg J Hallman L Oreland 2000b The genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity. Neurosci Lett 291 204 206
20. M Damberg J Ekblom L Oreland 2000c Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2. Life Sci 68 669 678
21. M Damberg M Eller M Tõnissaar L Oreland J Harro 2001a Levels of transcription factors AP-2α and AP-2β in the brainstem are correlated to monoamine levels in the rat forebrain. Neurosci Lett 313 102 104
22. M Damberg H Garpenstrand J Hallman L Oreland 2001b Genetic mechanisms of behaviour-don't forget about the transcription factors. Mol Psychiatry 6 503 510
23. M Damberg C Berggard M Mattila-Evenden G Rylander K Forslund H Garpenstrand H Bergman JP Gustavsson EG Jonsson 2003a Transcription factor AP-2beta genotype associated with anxiety-related personality traits in women. A replication study. Neuropsychobiology 48 4 169 175
24. M Damberg C Berggard L Oreland 2003b Phenelzine treatment increases transcription factor AP-2 levels in rat brain. BMC Pharmacol 3 10
25. M Damberg C Berggard L Farde GC Sedvall EG Jonsson 2004 Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. J Neural Transm 111 537 545
26. M Damberg L Westberg C Berggård M Landen C Sundblad O Eriksson T Naessén A Ekman E Eriksson 2005 Investigation of transcription factor AP-2beta genotype in women with premenstrual dysphoric disorder. Neurosci Lett 377 1 49 52
27. AF Davies RJ Stephens MG Olavsen L Heather MJ Dixon A Magee F Flinter J Ragoussis 1995 Evidence of a locus for orofacial clefting on human chromosome 6p24 and STS content map of the region. Hum Mol Genet 4 121 128
28. RA Depue PF Collins 1999 Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22 491 569
29. YL Du BD Wilcox M Teitler JJ Jeffrey 1994 Isolation and characterization of the rat 5-hydroxitryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 45 1125 1131
30. RS Duman GR Heninger EJ Nestler 1994 Molecular psychiatry. Adaptations of receptorcoupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 182 12 692 700
31. RS Duman J Malberg J Thome 1999 Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46 9 1181 1191
32. JG Emery EH Ohlstein M Jaye 2001 Therapeutic modulation of transcription factor activity. Trends Pharmacol Sci 22 233 240
33. E Eriksson 1999 Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. Int Clin Psychopharmacol 14 S27 S33
34. E Eriksson B Andersch HP Ho M Landen C Sundblad 2002 Diagnosis and treatment of premenstrual dysphoria. J Clin Psychiatry 63 7 16 23
35. E Eriksson MA Hedberg B Andersch C Sundblad 1995 The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of prementrual syndrome. Neuropsychopharmacology 12 167 176
36. M Foot D Koszycki 2004 Gender differencies in anxiety-related traits in patients with panic disorder. Depression Anxiety 20 123 130
37. D Greco E Zellmer Z Zhang E Lewis 1995 Transcription factor AP-2 regulates expression of the dopamine β-hydroxylase gene. J Neurochem 65 510 516
38. SL Hahn M Hahn UJ Kang TH Joh 1993 Structure of the rat aromatic L-amino acid decarboxylase gene: evidence for an alternative promoter usage. J Neurochem 60 1058 1064
39. J Hartmann G Kunig P Riederer 1993 Involvement of transmitter systems in neuropsychiatric diseases. Acta Neurol Scand (Suppl) 146 18 21
40. DP Healy DA O'Rourke 1997 Regulation of dopamine-1A (D1A) receptor gene transcription. Clin Exp Hypertens 19 1 13
41. A Heguy AA Stewart JD Haley DE Smith JG Foulkes 1995 Gene expression as a target for new drug discovery. Gene Expr 4 6 337 344
42. CJ Hudson LT Young PP Li JJ Warsh 1993 CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Synapse 13 3 278 293
43. LH Hurley 1989 DNA and associated targets for drug design. J Med Chem 32 9 2027 2033
44. M Imagawa R Chiu M Karin 1987 Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51 251 260
45. KJ Irizarry B Merriman ME Bahamonde ML Wong J Licinio 2005 The evolution of signaling complexity suggests a mechanism for reducing the genomic search space in human association studies. Mol Psychiatry 10 1 14 26
46. E Jönsson M Damberg K Forslund M Mattila-Evenden G Rylander M Åsberg L Oreland G Sedvall 2002 No association between a transcription factor activating protein 2beta (AP-2beta) gene variant and schizophrenia. Neurosci Lett 330 290
47. Y Kawanishi S Harada H Tachikawa T Okubo H Shiraishi 2000 Novel polymorphisms of the AP-2 gene (6p24): analysis of association with schizophrenia. J Hum Genet 45 24 30
48. JM Kent JD Coplan JM Gorman 1998 Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry 44 812 824
49. CH Kim P Ardayfio KS Kim 2001 An E-box motif residing in the exon/intron 1 junction regulates both transcriptional activation and splicing of the human norepinephrine transporter gene. J Biol Chem 276 24797 24805
50. HS Kim SJ Hong MS LeDoux KS Kim 2001 Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2. J Neurochem 76 280 294
51. E Kjelsås LB Augestad 2004 Gender, eating behavior, and personality characteristics in physically active students. Scand J Med Sci Sports 14 258 268
52. K Kobayashi Y Kurosawa K Fujita T Nagatsu 1989 Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucl Acids Res 17 3 1089 1102
53. GF Koob EJ Nestler 1997 The neurobiology of drug addiction. J Neuropsychiatr Clin Neurosci 9 482 497
54. A Laakso E Wallius J Kajander J Bergman O Eskola O Solin T Ilonen RKR Salokangas E Syvälathi J Hietala 2003 Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry 160 904 910
55. M Linnoila M Virkkunen T George D Higley 1993 Impulse control disorders. Int Clin Psychopharmacol 8 Suppl 1 53 56
56. KP Lesch 2001 Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 62 57 76
57. KP Lesch 2004 Gene-environment interactions and the genetics of depression. J Psychiatr Neurosci 29 3 174 184
58. KP Lesch A Heils 2000 Serotonergic gene transcriptional control regions: targets for antidepressant drug development? Int J Neuropsychopharmacol 3 67 79
59. KP Lesch U Merschdorf 2000 Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 18 581 604
60. I Lucki 1998 The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44 151 162
61. HK Manji R McNamara G Chen RH Lenox 1999 Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness. Aust NZ J Psychiatry 33 Suppl S65 S83
62. M McDonough N Kennedy 2002 Pharmacological management of obsessive-compulsive disorder: a review for clinicians. Harv Rev Psychiatry 10 127 137
63. M McMahon E Sabban 1992 Regulation of expression of dopamine β-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J Neurochem 59 2040 2204
64. PJ Mitchell C Wang R Tjian 1987 Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50 847 861
65. PJ Mitchell PM Timmons JM Herbert PW Rigby R Tjian 1991 Transcription factor AP-2 is expressed in neural crest lineages during mouse embryogenesis. Genes Dev 5 105 119
66. R Mongeau P Blier de Montigny 1997 The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 23 3 145 195
67. M Morishita T Kishino K Furukawa A Yonekura Y Miyazaki T Kanematsu S Yamashita T Tsukazaki 2001 A 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5. Biochem Biophys Res Commun 288 347 355
68. M Moser A Imhof A Pscherer R Bauer W Amselgruber F Sinowatz F Hofstadter R Schule R Buettner 1995 Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 121 2779 2788
69. M Moser J Rüschoff R Buettner 1997a Comparative analysis of AP-2α and AP-2β gene expression during murine embryogenesis. Dev Dyn 208 115 124
70. M Moser A Pscherer C Roth J Becker G Mücher K Zerres C Dixkens J Weis L Guay-Woodford R Buettner R Fässler 1997b Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2β. Genes Dev 11 1938 1948
71. MJ Nibuya EJ Nestler R Duman 1996 Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 7 2365 2372
72. L Oreland EG Shaskan 1983 Monoamine oxidase activity as a biological marker. Trends Pharmacol Sci 4 339 341
73. M Oulad-Abdelghani P Bouillet C Chazaud P Dolle P Chambon 1996 AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp Cell Res 225 338 347
74. T Palomo RJ Beninger RM Kostrzewa T Archer 2004 Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes. Neurotox Res 6 3 159 173
75. AG Papavassiliou 1998 Transcription-factor-modulating agents: precision and selectivity in drug design. Mol Med Today 4 358 366
76. KR Pennypacker 1995 Pharmacological regulation of transcription factor binding. Pharmacology 51 1 12
77. A Petronis II Gottesman TJ Crow LE DeLisi AJ Klar F Macciardi MG McInnis FJ McMahon AD Paterson D Skuse GR Sutherland 2000 Psychiatric epigenetics: a new focus for the new century. Mol Psychiatry 5 4 342 346
78. M Popoli N Brunello J Perez G Racagni 2000 Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs. J Neurochem 74 1 21 33
79. C Quirin-Stricker C Mauvais M Schmitt 1997 Transcriptional activation of human choline acetyltransferase by AP2- and NGF-induced factors. Brain Res Mol Brain Res 49 165 174
80. WJ Roesler GR Vandenbark RW Hanson 1988 Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 263 9063 9066
81. A Sawa SH Snyder 2002 Schizophrenia: diverse approaches to a complex disease. Science 296 5568 692 695
82. SG Schwab M Albus J Hallmeyer S Hönig M Borrman D Lichtermann RP Ebstein M Ackenheil B Lerer N Risch W Maier DB Wildenauer 1995 Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 11 325 327
83. M Shimada Y Konishi N Ohkawa C Ohtaka-Maruyama F Hanaoka Y Makino T Tamura 1999 Distribution of AP-2 subtypes in the adult mouse brain. Neurosci Res 33 275 280
84. DJ Stein HG Westenberg MR Liebowitz 2002 Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry 63 Suppl 6 12 19
85. F Sulser 1989 New perspectives on the molecular pharmacology of affective disorders. Eur Arch Psychiatry Neurol Sci 238 5-6 231 239
86. KH Surinya TC Cox BK May 1998 Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem 273 16798 16809
87. S Takeuchi M Waragi C Roth I Kanazawa R Buettner MM Mouridan H Kazawa 1999 Brain Res Mol Brain Res 74 208
88. J Thome N Sakai K Shin C Steffen YJ Zhang S Impey D Storm RS Duman 2000 cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20 11 4030 4036
89. G Van Haasteren S Li S Ryser W Schlegel 2000 Essential contribution of intron sequences to Ca(2+)-dependent activation of c-fos transcription in pituitary cells. Neuroendocrinology 72 368 378
90. HV Wang K Vaupel R Buettner AK Bosserhoff M Moser 2004 Identification and embryonic expression of a new AP-2 transcription factor, AP-2epsilon. Dev Dyn 231 128 135
91. S Wang CE Sun CA Walczak JS Ziegle BR Kipps LR Goldin SR Diehl 1995 Evidence for a susceptibility locus for schizophrenia on chreomosaome 6pter-p22. Nat Genet 10 40 46
92. T Williams A Admon B Luscher R Tjian 1988 Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2 1557 1569
93. T Williams R Tjian 1991a Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 5 670 682
94. T Williams R Tjian 1991b Characterization of a dimerization motif in AP-2 and its function in heterologous DNA binding proteins. Science 251 1067 1071
95. F Zhao M Satoda JD Licht Y Hayashizaki BD Gelb 2001 Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 276 40755 40760
96. M Zuckerman 1993 P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuropsychobiology 28 30 36